1. Home
  2. BCYC vs FPI Comparison

BCYC vs FPI Comparison

Compare BCYC & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • FPI
  • Stock Information
  • Founded
  • BCYC 2009
  • FPI 2013
  • Country
  • BCYC United Kingdom
  • FPI United States
  • Employees
  • BCYC N/A
  • FPI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • FPI Real Estate Investment Trusts
  • Sector
  • BCYC Health Care
  • FPI Real Estate
  • Exchange
  • BCYC Nasdaq
  • FPI Nasdaq
  • Market Cap
  • BCYC 566.5M
  • FPI 516.0M
  • IPO Year
  • BCYC 2019
  • FPI 2014
  • Fundamental
  • Price
  • BCYC $7.44
  • FPI $11.59
  • Analyst Decision
  • BCYC Buy
  • FPI
  • Analyst Count
  • BCYC 10
  • FPI 0
  • Target Price
  • BCYC $25.00
  • FPI N/A
  • AVG Volume (30 Days)
  • BCYC 274.8K
  • FPI 475.7K
  • Earning Date
  • BCYC 08-05-2025
  • FPI 07-23-2025
  • Dividend Yield
  • BCYC N/A
  • FPI 2.08%
  • EPS Growth
  • BCYC N/A
  • FPI 104.48
  • EPS
  • BCYC N/A
  • FPI 1.09
  • Revenue
  • BCYC $25,722,000.00
  • FPI $56,535,000.00
  • Revenue This Year
  • BCYC $7.35
  • FPI N/A
  • Revenue Next Year
  • BCYC N/A
  • FPI N/A
  • P/E Ratio
  • BCYC N/A
  • FPI $10.63
  • Revenue Growth
  • BCYC N/A
  • FPI N/A
  • 52 Week Low
  • BCYC $6.10
  • FPI $9.66
  • 52 Week High
  • BCYC $28.67
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 44.12
  • FPI 60.50
  • Support Level
  • BCYC $6.87
  • FPI $11.37
  • Resistance Level
  • BCYC $7.59
  • FPI $11.52
  • Average True Range (ATR)
  • BCYC 0.46
  • FPI 0.17
  • MACD
  • BCYC -0.06
  • FPI -0.03
  • Stochastic Oscillator
  • BCYC 29.69
  • FPI 100.00

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: